Understand before treating
The first task is not selecting a medication or protocol. It is understanding what is actually happening—and what may have been missed.
PSYCHIATRY · NEUROMODULATION · CARE
Tobias B HaleneMD, PhD
Psychiatry for the individual, not the diagnosis.
Co-founder · Medical Director, NeuroSynchrony Health
Board-Certified Psychiatry · TMS · Greenwich, Connecticut
View profileCatch a brighter node and move slowly
01
Professional profile
Physician first. Psychiatrist always. Scientist by training.
Tobias B Halene, MD, PhD is a board-certified psychiatrist and physician-scientist licensed in Connecticut and New York. Born and raised in Germany, he studied medicine in Germany and Italy before moving to the United States for doctoral research at the University of Pennsylvania, followed by psychiatry residency and research fellowship training through Mount Sinai Medical Center and the James J. Peters VA Medical Center. Across nearly two decades, his work has included outpatient and emergency psychiatry, Veterans Health Administration care, academic research, teaching, psychotherapy, psychopharmacology, and neuromodulation.
Clinical range
- General & complex psychiatry
- Psychopharmacology & psychotherapy-informed care
- TMS & brain-network modulation
- Research, teaching & supervision
02
Working philosophy
Scientific without becoming mechanical. Humane without becoming vague.
The brain and the person are not competing explanations. Diagnosis, neuroscience, medication, psychotherapy, sleep, relationships, behavior, culture, physical health, and the circumstances of a life all belong in the same clinical picture. Each is a tool for understanding—not an ideology.
“Treat the person. Measure what matters. Use the full toolbox. Stay honest about the evidence.”
Measure what matters
A questionnaire can sharpen judgment, but it cannot replace a conversation. Progress also means better sleep, clearer thinking, restored work, relationships, autonomy, and participation in life.
Hope without hype
Innovation requires skepticism. Where evidence is strong, say so. Where it is preliminary, say so. Scientific humility is part of good clinical care.
03
A distinction that matters
Difficult to treat does not mean untreatable.
I prefer difficult-to-treat depression to “treatment-resistant depression.” The latter can make a complex illness sound biologically predetermined—and can subtly leave patients feeling that they have somehow failed treatment.
Difficult cases ask the clinician to think harder: to reconsider the diagnosis, previous treatment, sleep, medical contributors, substances, psychosocial circumstances, psychotherapy, neurobiology, and sometimes a different treatment modality. “Difficult” should sharpen clinical thinking. It should not diminish hope.
Connect